Po$itive Times Ahead.

Time has been ticking away and the Company have been slowly but surely ticking all the boxes. 

One of the very most important facts not to be overlooked during the Doldrums of no substantial news is ;

Forty-five per cent of patients in Dimerix’s (ASXXB) successful Phase 2a trial in chronic kidney disease (CKD), on advice from their physician, applied for and were granted access to remain on DMX-200 under Australia’s Special Access Scheme, which allows participants continued access to a therapy after they complete a clinical study.

“This demonstrates physicians’ confidence that DMX-200 was having a positive effect on their patients,” Kathy Harrison, CEO, says in an interview with BioTuesdays.

Ms. Harrison explains that physicians’ recommendations were based on patients classified as responders in the trial; achieving a reduction of proteinuria, or protein leaking into the urine because of damage to the kidneys; or a 50% or greater increase in proteinuria four weeks after dosing ceased, suggesting that DMX-200 may have had a potential benefit in slowing disease progression.

A very important part of what Kathy was accomplishing was Intellectual Property Protection, ring fencing DXB discovery..

Also Kathy and DXB have and are in constant discussions with commercialising partners,,, there has been substantial interest in DXB Technology, Big Pharma have reduced their direct investment into R and D opting to buy positive resulting minor Biotechs and Baby Pharma, the sit back and pick winners approach.

Now as the recruiting takes place , we should err on the side of Optimism ,, this is exactly the defining point we have been striving toward..

For those others who have been in Biotechs over the years,, many dont even get to this point,, DXB is well respected in the Scientific community.

I feel a licensing Deal or outright purchase of the Technology is not that far away,,, I for one am feeling the tide has turned and now DXB is ready for a steady SP climb that reflects the Value that has been established by Management and the patients of DXB shareholders,, Reward time is on the Horizon... don't lose sight or enthusiasm as we approach the finish line.... NZT